ICU Medical, Inc. $ICUI Shares Sold by Deutsche Bank AG

Deutsche Bank AG trimmed its position in ICU Medical, Inc. (NASDAQ:ICUI) by 7.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,208 shares of the medical instruments supplier’s stock after selling 1,584 shares during the quarter. Deutsche Bank AG owned approximately 0.08% of ICU Medical worth $2,806,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. GAMMA Investing LLC raised its holdings in shares of ICU Medical by 27.2% in the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier’s stock valued at $99,000 after purchasing an additional 153 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of ICU Medical in the 1st quarter valued at $859,000. Vontobel Holding Ltd. acquired a new stake in shares of ICU Medical in the 1st quarter valued at $235,000. Russell Investments Group Ltd. raised its stake in ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after acquiring an additional 300 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in ICU Medical by 8.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 20,269 shares of the medical instruments supplier’s stock worth $2,815,000 after acquiring an additional 1,534 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ICUI has been the topic of several research analyst reports. Wall Street Zen lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Raymond James Financial cut their price target on shares of ICU Medical from $187.00 to $180.00 and set a “strong-buy” rating on the stock in a research note on Friday, August 8th. Finally, Piper Sandler initiated coverage on shares of ICU Medical in a research note on Friday. They set an “overweight” rating and a $145.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $179.00.

ICU Medical Trading Up 0.7%

NASDAQ ICUI opened at $123.76 on Wednesday. The firm has a market cap of $3.06 billion, a PE ratio of -81.42 and a beta of 0.88. The firm’s fifty day moving average is $127.68 and its two-hundred day moving average is $137.63. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44. ICU Medical, Inc. has a one year low of $107.00 and a one year high of $196.26.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.66. The business had revenue of $543.57 million for the quarter, compared to the consensus estimate of $543.33 million. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The business’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.56 earnings per share. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. Analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insider Activity

In other news, CEO Vivek Jain bought 21,929 shares of the stock in a transaction dated Thursday, August 14th. The shares were acquired at an average price of $112.84 per share, with a total value of $2,474,468.36. Following the completion of the acquisition, the chief executive officer directly owned 130,149 shares in the company, valued at approximately $14,686,013.16. The trade was a 20.26% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Christian B. Voigtlander sold 4,985 shares of ICU Medical stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total transaction of $640,572.50. Following the completion of the sale, the chief operating officer directly owned 6,088 shares in the company, valued at approximately $782,308. The trade was a 45.02% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 14,889 shares of company stock worth $1,933,186. Insiders own 1.50% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.